Global Cochler Implants Market Market Companies
- MED-EL Corporation
- Sonova Holding AG
- Gaes SA
- William Demant Holding A/S
- Nurotron Biotechnology Co. Ltd.
- Advanced Bionics AG
- Microson S.A.
- Widex Polska Sp. z.o.o.
- Demant A/S
Recent News:
- With FDA clearance, Marvel CI, a cochlear implant technology leader, will now be able to improve patient outcomes and the way that hearing care is delivered. This announcement was made in December 2023 by Advanced Bionics AG and affiliates. This innovation improves accessibility to hearing care for cochlear implant (CI) users by enabling remote programming through the use of the AB Remote Support software on a patient's smartphone.
- The FDA authorized Cochlear Ltd. in January 2022 to treat single-sided deafness (SSD) in patients using the Cochlear Nucleus System. Patients now have additional options for treatment, including bone conduction therapies and cochlear implants, thanks to this approval.
- With the announcement of the establishment of its global manufacturing site in Kuala Lumpur, in October 2022, Cochlear Ltd., the world leader in implanted hearing solutions, elevated Malaysia as a global leader in the production and maintenance of hearing implant sound processors. The company is investing more than USD 6 million in this expansion to address the growing demand for cochlear and acoustic hearing implants in Malaysia and over 180 other countries globally.